Filing Details

Accession Number:
0001104659-12-017926
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-13 17:04:05
Reporting Period:
2012-03-09
Filing Date:
2012-03-13
Accepted Time:
2012-03-13 17:04:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1232524 Jazz Pharmaceuticals Plc JAZZ Pharmaceutical Preparations (2834) 981032470
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1397661 W Kenneth O'keefe C/O Beecken Petty O' Keefe &Amp; Company
131 Dearborn St., Suite 2800
Chicago IL 60603
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2012-03-09 600,000 $49.56 769,237 No 4 S Indirect By Fund II and Fund II GP (as defined in footnote 1)
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Fund II and Fund II GP (as defined in footnote 1)
Footnotes
  1. Beecken Petty O'Keefe Fund II, L.P., Beecken Petty O'Keefe QP Fund II, L.P. and Beecken Petty O'Keefe Executive Fund II, L.P. as tenants in common (collectively, "Fund II") and Beecken Petty O'Keefe & Company II, L.P. (the "Fund II GP") are the holders. The Fund II GP is the general partner of Fund II and Beecken Petty O'Keefe & Company, LLC is the general partner of the Fund II GP. The Reporting Person is a partner at Beecken Petty O'Keefe & Company, LLC and shares voting and investment power over the shares held by Fund II and the Fund II GP. The Reporting Person disclaims beneficial ownership of the shares held by Fund II and the Fund II GP except to the extent of his proportionate pecuniary interest therein.